These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11565542)

  • 1. A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels.
    Brouwers GJ; Vos HL; Leebeek FW; Bulk S; Schneider M; Boffa M; Koschinsky M; van Tilburg NH; Nesheim ME; Bertina RM; Gómez Garcia EB
    Blood; 2001 Sep; 98(6):1992-3. PubMed ID: 11565542
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms.
    Trégouet DA; Aubert H; Henry M; Morange P; Visvikis S; Juhan-Vague I; Tiret L
    Hum Genet; 2001 Aug; 109(2):191-7. PubMed ID: 11511925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN; Marx PF; Mosnier LO; Meijers JC
    Thromb Res; 2001 Mar; 101(5):329-54. PubMed ID: 11297751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation analysis of thrombin-activatable fibrinolysis inhibitor single nucleotide polymorphism with venous thromboembolism].
    Li C; Hou LH; Liu XE; Huang C; Wei XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):949-53. PubMed ID: 22931662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease.
    Kremer Hovinga JA; Franco RF; Zago MA; Ten Cate H; Westendorp RG; Reitsma PH
    J Thromb Haemost; 2004 Jan; 2(1):54-7. PubMed ID: 14717966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP; Blombäck M
    Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].
    González FJ; Caturla JM; Fernández M; Carrasco R; Marco P; Sánchez J; Benlloch S
    Med Intensiva; 2010 Nov; 34(8):513-22. PubMed ID: 20627371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.
    Henry M; Aubert H; Morange PE; Nanni I; Alessi MC; Tiret L; Juhan-Vague I
    Blood; 2001 Apr; 97(7):2053-8. PubMed ID: 11264171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.
    van Tilburg NH; Rosendaal FR; Bertina RM
    Blood; 2000 May; 95(9):2855-9. PubMed ID: 10779431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis.
    Mook-Kanamori BB; Valls Serón M; Geldhoff M; Havik SR; van der Ende A; Baas F; van der Poll T; Meijers JC; P Morgan B; Brouwer MC; van de Beek D
    J Thromb Haemost; 2015 Nov; 13(11):2076-86. PubMed ID: 26340319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men.
    Meltzer ME; Doggen CJ; de Groot PG; Meijers JC; Rosendaal FR; Lisman T
    Haematologica; 2009 Jun; 94(6):811-8. PubMed ID: 19377074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.
    Hryszko T; Malyszko J; Malyszko JS; Brzosko S; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Aug; 16(8):1692-6. PubMed ID: 11477176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.
    Stanne TM; Olsson M; Lorentzen E; Pedersen A; Gummesson A; Gils A; Jood K; Engström G; Melander O; Declerck PJ; Jern C
    Thromb Haemost; 2018 Feb; 118(2):298-308. PubMed ID: 29378355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma thrombin-activatable fibrinolysis inhibitor levels and Thr325Ile polymorphism as a risk marker of myocardial infarction in Egyptian patients.
    Kamal HM; Ahmed AS; Fawzy MS; Mohamed FA; Elbaz AA
    Acta Cardiol; 2011 Aug; 66(4):483-8. PubMed ID: 21894805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension.
    Yaoita N; Satoh K; Satoh T; Sugimura K; Tatebe S; Yamamoto S; Aoki T; Miura M; Miyata S; Kawamura T; Horiuchi H; Fukumoto Y; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1293-301. PubMed ID: 27102961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
    Juhan-Vague I; Morange PE; Aubert H; Henry M; Aillaud MF; Alessi MC; Samnegård A; Hawe E; Yudkin J; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):867-73. PubMed ID: 12006404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of unactivated thrombin activatable fibrinolysis inhibitor (TAFI) are down-regulated in young adult women: analysis of a normal Japanese population.
    Akatsu H; Ishiguro M; Ogawa N; Kanesaka T; Okada N; Yamamoto T; Campbell W; Okada H
    Microbiol Immunol; 2007; 51(5):507-17. PubMed ID: 17579260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion.
    ElDanasori N; Abulata N; Shaheen IA; ElGendy AM; El-Khayat W
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):532-535. PubMed ID: 28301909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.
    Bajzar L; Nesheim ME; Tracy PB
    Blood; 1996 Sep; 88(6):2093-100. PubMed ID: 8822928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.